When disease-free survival was evaluated as an endpoint in this GBM patient cohort, a low copy number of the NKR ligand gene NCR3LG1 (B7-H6) (p = 0.00001145) was associated with a poorer disease-free survival (Figure 1B). The gene discussed is NCR3LG1; the disease is glioblastoma.